N46 N97
Conditions
Interventions
Group 1: Intrauterine application of 500 IU hCG (Pregnyl, ORGANON, Netherlands) dissolved in 40 µl embryo culture medium G-2™ PLUS (Vitrolife, Sweden) on day 3 after ovum pick up.
Group 2: Intrauterin
Sponsors
IVF-Zentren Prof. Zech, Pilsen
Eligibility
Sex/Gender
All
Age
18 Years to 43 Years
Inclusion criteria
Inclusion criteria: Included were all fresh blastocyst transfers on day 5 after ovum pick up
Exclusion criteria
Exclusion criteria: Female age =44 years (no age limit for male partner) Known chromosomal aberration either by female or by male partner IVF-cycles with preimplantation genetic analysis IVF-cycles with use of donor oocytes Patients with recurrent implantation failure (=3 negative IVF-cycles)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implantation rate (number implanted embryos/ number transfered embryos; pregnancy rate: number positive pregnancy tests (beta-hCG) / number embryo transfers, clinical pregnancy rate: number of verified pregnancy tests by fetal heart beat / number embryo transfers; miscarriage rates: miscarriages/ number of embryo transfers; Live birth rates: number of deliveries / embryo transfers | — |
Secondary
| Measure | Time frame |
|---|---|
| Miscarriage rate after foetal heartbeat (miscarriages /verfied ckinical pregnancies) Live birth rate (Live birth / embryos transferred) | — |
Countries
Czechia
Contacts
Public ContactLibor Hradecký
IVF-Zentren Prof. Zech, Pilsen
Outcome results
None listed